Executive Summary
A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels - Hospital & Clinics, Retail Pharmacies, Others.
A research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market By Region (North America, Europe, Asia Pacific and Rest of the world) and By Country (U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia) for the historical period of 2013-2017 and forecast period of 2018-2023.
According to Azoth Analytics research report, "Global Antidepressant Drugs Market - Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)" global antidepressants market is projected to display a robust growth represented by a CAGR of 3.12 % during 2018 - 2023.
The segment of Selective Serotonin Reuptake Inhibitors (SSRIs) drug class witnessed growth at a noteworthy rate over the past few years and in the forecast period on the back of rising awareness related metal disorders, rising healthcare expenditures along with rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global antidepressant drugs market in 2017. Key factors driving the robust growth rate of North America region include rising healthcare expenditure, addition of new drugs, rising disposable incomes, rising number of hospitals and clinics etc.
The report titled "Global Antidepressant Drugs Market - Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)" has covered and analysed the potential of Global Antidepressants Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global antidepressants drug. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Antidepressants Market, By Value (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antidepressant Drugs Market - Sizing and Growth
Analysis By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents
Analysis By Sales Channels - Hospital & Clinics, Retail Pharmacies, Others
Regional Markets - North America, Europe, APAC and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antidepressant Drugs Market - Sizing and Growth
Analysis By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents
Analysis By Sales Channels - Hospital & Clinics, Retail Pharmacies, Others
Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antidepressant Drugs Market - Sizing and Growth
Analysis By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents
Other Report Highlights
• Market Dynamics - Drivers and Restraints
• Market Trends
• Porter Five Force Analysis
• Policy and Regulatory Landscape
• Company Analysis - Pfizer, GlaxoSmithKline, Allergan, Forest laboratories, Takeda, Novartis, Eli Lilly
Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.
Request Sample 
Request Discount 
Inquire Before BuyTable of Content
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Antidepressant Drugs Market Outlook
5. Global Antidepressant Drugs Market: Growth and Forecast
5.1. By Value (2013-2017)
5.2. By Value (2013-2017)
6. Global Antidepressant Drugs Market: By Drugs Class
6.1. Global Antidepressant Drugs Market-By Drugs Class: Breakdown (%)
6.1.1. Global Antidepressant Drugs Market Size and Share, By Drugs, 2017
6.1.2. Global Antidepressant Drugs Market Size and Share, By Drugs, 2023
6.2. Global Selective Serotonin Reuptake Inhibitors Market Overview
6.2.1. By Value (2013-2023)
6.3. Global Serotonin and Norepinephrine Reuptake Inhibitors Market Overview
6.3.1. By Value (2013-2023)
6.4. Global Monoamine Oxidase Inhibitors Market Overview
6.4.1. By Value (2013-2023)
6.5. Global Tricyclic Antidepressant Drugs Market Overview
6.5.1. By Value (2013-2023)
6.6. Global Benzodiazepines Antidepressant Drugs Market Overview
6.6.1. By Value (2013-2023)
6.7. Global Antipsychotics Antidepressant Drugs Market Overview
6.7.1. By Value (2013-2023)
6.8. Global Novel Agents Antidepressant Drugs Market Overview
6.8.1. By Value (2013-2023)
6.9. Global Other Antidepressant Drugs Market Overview
6.9.1. By Value (2013-2023)
7. Global Antidepressant Drugs Market: By Sales Channels
7.1. Global Antidepressant Drugs Market-By Sales Channels: Breakdown (%)
7.1.1. Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2017
7.1.2. Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2023
7.2.Global Antidepressant Drugs Market, By Hospital & Clinics Overview
7.2.1. By Value (2013-2023)
7.3. Global Antidepressant Drugs Market, By Retail Pharmacies Overview
7.3.1. By Value (2013-2023)
7.4. Global Antidepressant Drugs Market, By Others Overview
7.4.1. By Value (2013-2023)
8. Global Antidepressant Drugs Market: Pipeline Analysis
9. Global Antidepressant Drugs Market: Regional Analysis
9.1. Global Antidepressant Drugs Market, By Region: Breakdown (%)
9.1.1. Global Antidepressant Drugs Market Size, By Region, 2017 (%)
9.1.2. Global Antidepressant Drugs Market Size, By Region, 2023 (%)
9.2. Global Antidepressant Drugs Market Size, By Region, 2023 (%)
9.2.1. By Value (2013-2017)
9.2.2. By Value (2018-2023)
9.3. North America Antidepressant Drugs Market: Segment Analysis
9.3.1. North America Antidepressant Drugs Market: By Drug Class
9.3.1.1.North America Antidepressant Drugs Market Size, By Value, 2013-2023
9.3.2. North America Antidepressant Drugs Market: By Sales Channels
9.3.2.1. North America Antidepressant Drugs Market Size, By Value, 2013-2023F
9.4. North America Antidepressant Drugs Market: Country Analysis (U.S. and Canada)
9.4.1. U.S. Antidepressant Drugs Market, By Value (2013-2023)
9.4.1.1. U.S. Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.4.2. Canada Antidepressant Drugs Market, By Value (2013-2023)
9.4.2.1. Canada Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.5. Europe Antidepressant Drugs Market: An Analysis
9.5.1. By Value (2013-2017)
9.5.2. By Value (2018-2023)
9.6. Europe Antidepressant Drugs Market: Segment Analysis
9.6.1. Europe Antidepressant Drugs Market: By Drug Class
9.6.1.1. Europe Antidepressant Drugs Market Size, By Value, 2013-2023
9.6.2. Europe Antidepressant Drugs Market: By Sales Channels
9.6.2.1. Europe Antidepressant Drugs Market Size, By Value, 2013-2023F
9.7. Europe Antidepressant Drugs Market: Country Analysis (U.K., Germany & Rest of Europe)
9.7.1. United Kingdom Antidepressant Drugs Market, By Value (2013-2023)
9.7.1.1. United Kingdom Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.7.2. Germany Antidepressant Drugs Market, By Value (2013-2023)
9.7.2.1. Germany Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.7.3. Rest of Europe Antidepressant Drugs Market, By Value (2013-2023)
9.8. Asia Pacific Antidepressant Drugs Market: An Analysis
9.8.1. By Value (2013-2017)
9.8.2. By Value (2018-2023)
9.9. Asia Pacific Antidepressant Drugs Market: Segment Analysis
9.9.1. Asia Pacific Antidepressant Drugs Market: By Drug Class
9.9.1.1. Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023
9.9.2. Asia Pacific Antidepressant Drugs Market: By Sales Channels
9.9.2.1. Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023F
9.10. Asia Pacific Antidepressant Drugs Market: Country Analysis (Germany, U.K., & Rest of Europe)
9.10.1. India Antidepressant Drugs Market, By Value (2013-2023)
9.10.1.1. India Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.10.2. China Antidepressant Drugs Market, By Value (2013-2023)
9.10.2.1. China Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.10.3. Japan Antidepressant Drugs Market, By Value (2013-2023)
9.10.3.1. Japan Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.10.4. Rest of Asia Pacific Antidepressant Drugs Market, By Value (2013-2023)
9.11. Rest of World Pacific Antidepressant Drugs Market: An Analysis
9.11.1. By Value (2013-2017)
9.11.2. By Value (2018-2023)
9.12. Rest of World Antidepressant Drugs Market: Segment Analysis
9.12.1. Rest of World Antidepressant Drugs Market: By Drug Class
9.12.1.1. Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023
9.12.2. Rest of World Antidepressant Drugs Market: By Sales Channels
9.12.2.1. Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023F
9.13. Rest of World Antidepressant Drugs Market: Country Analysis (Brazil, Saudi Arabia & Others)
9.13.1. Brazil Antidepressant Drugs Market, By Value (2013-2023)
9.13.1.1. Brazil Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.13.2. Saudi Arabia Antidepressant Drugs Market, By Value (2013-2023)
9.13.2.1. Saudi Arabia Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
9.13.3. Others Antidepressant Drugs Market, By Value (2013-2023)
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends
12. Policy and Regulatory Landscape
13. Porter's Five Forces Analysis - Antidepressant Drugs Market
14. SWOT Analysis - Antidepressant Drugs Market
15. Company Profiles
15.1. Allergan
15.2. Eli Lilly
15.3. Pfizer
15.4. Takeda
15.5. GlaxoSmithKline
15.6. Novartis
15.7. Forest Laboratories
| Price : US$ 3500 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 132 |
| Price : US$ 2955 | Date : Jul 2024 |
| Category : Medical Devices | Pages : 143 |
| Price : US$ 2955 | Date : Jul 2024 |
| Category : Medical Devices | Pages : 140 |
| Price : US$ 2955 | Date : Jul 2024 |
| Category : Medical Devices | Pages : 135 |
| Price : US$ 3985 | Date : Jul 2024 |
| Category : Medical Devices | Pages : 162 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
